Lianne Messchendorp

Lianne Messchendorp is a medical researcher specializing in nephrology and transplantation medicine at the University Medical Center Groningen, part of the University of Groningen. Her work primarily focuses on kidney disease, transplantation, and the impact of infectious diseases like COVID-19 on vulnerable patient populations.

Education and Background

Dr. Messchendorp holds a doctoral degree (indicated by 'dr.' title) with expertise in nephrology and transplantation medicine. Her research career has centered on improving outcomes for patients with kidney disease and those who have undergone kidney transplantation.

Research Interests

Dr. Messchendorp's research spans several interconnected areas within nephrology and transplantation:

• Polycystic Kidney Disease and Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• COVID-19 vaccination responses in immunocompromised patients, particularly kidney transplant recipients
• Impact of immunosuppressive medications on vaccine efficacy
• Patient engagement in clinical research
• Long-term outcomes of kidney disease patients during the pandemic

Her work has been instrumental in understanding how kidney transplant recipients respond to COVID-19 vaccines and how immunosuppressive regimens affect vaccine efficacy. She has led several studies examining different vaccination strategies to optimize immune responses in this vulnerable population.

Scientific Contributions

Dr. Messchendorp has made significant contributions to the field through her research on:

• Optimizing vaccine protocols for kidney transplant recipients
• Understanding the relationship between antibody levels and clinical protection against COVID-19
• Assessing the burden of long COVID in patients with advanced kidney disease
• Developing strategies to improve vaccine immunogenicity in immunocompromised patients

Research Leadership and Collaboration

Dr. Messchendorp serves as a key investigator in the RECOVAC consortium, a collaborative research effort focused on COVID-19 vaccination in renal patients. She has led multiple clinical trials examining different immunosuppression modification strategies to enhance vaccine responses. Her work involves extensive collaboration with nephrologists, immunologists, and infectious disease specialists across multiple institutions.

Professional Engagement

Dr. Messchendorp is an active participant in the scientific community, regularly presenting her findings at professional conferences. She was an invited speaker at an event titled 'Effects of COVID-19 on kidney patients, and what can we learn from it' in October 2024. Her research has received media attention, with multiple press mentions regarding immunosuppressive drugs and COVID-19 hospitalization risk.